vs

Side-by-side financial comparison of Invesco (IVZ) and JBT Marel Corp (JBTM). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.0B, roughly 1.7× JBT Marel Corp). JBT Marel Corp runs the higher net margin — 5.3% vs -58.9%, a 64.1% gap on every dollar of revenue. On growth, JBT Marel Corp posted the faster year-over-year revenue change (115.6% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $83.5M). Over the past eight quarters, JBT Marel Corp's revenue compounded faster (60.3% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

JBT Marel Corporation, formerly known as JBT Corporation, or John Bean Technologies Corporation, is a food processing machinery and automated vehicle company. The company was incorporated in 2008 when FMC Technologies divested its non-energy businesses. The company is based in Chicago, Illinois and traces its history back to a company founded in 1884 by John Bean, an orchardist in Los Gatos, California.

IVZ vs JBTM — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.7× larger
IVZ
$1.7B
$1.0B
JBTM
Growing faster (revenue YoY)
JBTM
JBTM
+109.4% gap
JBTM
115.6%
6.2%
IVZ
Higher net margin
JBTM
JBTM
64.1% more per $
JBTM
5.3%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$348.7M more FCF
IVZ
$432.2M
$83.5M
JBTM
Faster 2-yr revenue CAGR
JBTM
JBTM
Annualised
JBTM
60.3%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVZ
IVZ
JBTM
JBTM
Revenue
$1.7B
$1.0B
Net Profit
$-995.9M
$53.1M
Gross Margin
34.5%
Operating Margin
-86.2%
7.2%
Net Margin
-58.9%
5.3%
Revenue YoY
6.2%
115.6%
Net Profit YoY
-575.8%
858.6%
EPS (diluted)
$-2.61
$1.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
JBTM
JBTM
Q4 25
$1.7B
$1.0B
Q3 25
$1.6B
$1.0B
Q2 25
$1.5B
$934.8M
Q1 25
$1.5B
$854.1M
Q4 24
$1.6B
$467.6M
Q3 24
$1.5B
$453.8M
Q2 24
$1.5B
$402.3M
Q1 24
$1.5B
$392.3M
Net Profit
IVZ
IVZ
JBTM
JBTM
Q4 25
$-995.9M
$53.1M
Q3 25
$356.4M
$66.0M
Q2 25
$197.4M
$3.4M
Q1 25
$171.1M
$-173.0M
Q4 24
$209.3M
$-7.0M
Q3 24
$55.0M
$38.9M
Q2 24
$132.2M
$30.7M
Q1 24
$141.5M
$22.8M
Gross Margin
IVZ
IVZ
JBTM
JBTM
Q4 25
34.5%
Q3 25
35.9%
Q2 25
35.8%
Q1 25
34.2%
Q4 24
38.4%
Q3 24
36.1%
Q2 24
35.6%
Q1 24
35.8%
Operating Margin
IVZ
IVZ
JBTM
JBTM
Q4 25
-86.2%
7.2%
Q3 25
16.5%
10.2%
Q2 25
14.1%
5.2%
Q1 25
18.1%
-3.9%
Q4 24
19.6%
3.4%
Q3 24
6.6%
10.3%
Q2 24
13.9%
6.7%
Q1 24
14.4%
7.4%
Net Margin
IVZ
IVZ
JBTM
JBTM
Q4 25
-58.9%
5.3%
Q3 25
21.7%
6.6%
Q2 25
13.0%
0.4%
Q1 25
11.2%
-20.3%
Q4 24
13.1%
-1.5%
Q3 24
3.6%
8.6%
Q2 24
8.9%
7.6%
Q1 24
9.6%
5.8%
EPS (diluted)
IVZ
IVZ
JBTM
JBTM
Q4 25
$-2.61
$1.04
Q3 25
$0.66
$1.26
Q2 25
$-0.03
$0.07
Q1 25
$0.38
$-3.35
Q4 24
$0.46
$-0.22
Q3 24
$0.12
$1.21
Q2 24
$0.29
$0.95
Q1 24
$0.31
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
JBTM
JBTM
Cash + ST InvestmentsLiquidity on hand
$1.0B
$167.9M
Total DebtLower is stronger
$1.8B
$1.5B
Stockholders' EquityBook value
$12.2B
$4.5B
Total Assets
$27.1B
$8.2B
Debt / EquityLower = less leverage
0.15×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
JBTM
JBTM
Q4 25
$1.0B
$167.9M
Q3 25
$973.1M
Q2 25
$922.7M
Q1 25
$821.7M
Q4 24
$986.5M
$1.2B
Q3 24
$1.0B
Q2 24
$878.5M
Q1 24
$895.7M
Total Debt
IVZ
IVZ
JBTM
JBTM
Q4 25
$1.8B
$1.5B
Q3 25
$1.6B
$1.5B
Q2 25
$1.9B
$1.5B
Q1 25
$964.8M
$2.0B
Q4 24
$890.6M
$1.3B
Q3 24
$890.3M
$648.3M
Q2 24
$890.1M
$647.7M
Q1 24
$1.3B
$647.0M
Stockholders' Equity
IVZ
IVZ
JBTM
JBTM
Q4 25
$12.2B
$4.5B
Q3 25
$14.0B
$4.4B
Q2 25
$13.9B
$4.4B
Q1 25
$14.7B
$4.1B
Q4 24
$14.6B
$1.5B
Q3 24
$14.8B
$1.6B
Q2 24
$14.6B
$1.5B
Q1 24
$14.6B
$1.5B
Total Assets
IVZ
IVZ
JBTM
JBTM
Q4 25
$27.1B
$8.2B
Q3 25
$28.4B
$8.2B
Q2 25
$28.5B
$8.3B
Q1 25
$28.1B
$8.0B
Q4 24
$27.0B
$3.4B
Q3 24
$27.5B
$2.8B
Q2 24
$27.2B
$2.7B
Q1 24
$28.1B
$2.7B
Debt / Equity
IVZ
IVZ
JBTM
JBTM
Q4 25
0.15×
0.33×
Q3 25
0.12×
0.34×
Q2 25
0.14×
0.35×
Q1 25
0.07×
0.48×
Q4 24
0.06×
0.81×
Q3 24
0.06×
0.41×
Q2 24
0.06×
0.43×
Q1 24
0.09×
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
JBTM
JBTM
Operating Cash FlowLast quarter
$455.8M
$117.4M
Free Cash FlowOCF − Capex
$432.2M
$83.5M
FCF MarginFCF / Revenue
25.5%
8.3%
Capex IntensityCapex / Revenue
1.4%
3.4%
Cash ConversionOCF / Net Profit
2.21×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$238.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
JBTM
JBTM
Q4 25
$455.8M
$117.4M
Q3 25
$606.2M
$87.7M
Q2 25
$547.9M
$102.2M
Q1 25
$-84.6M
$34.4M
Q4 24
$316.9M
$128.7M
Q3 24
$438.4M
$71.9M
Q2 24
$489.1M
$21.6M
Q1 24
$-54.4M
$10.4M
Free Cash Flow
IVZ
IVZ
JBTM
JBTM
Q4 25
$432.2M
$83.5M
Q3 25
$586.4M
$56.5M
Q2 25
$530.4M
$83.7M
Q1 25
$-108.0M
$14.4M
Q4 24
$309.9M
$118.7M
Q3 24
$410.0M
$65.0M
Q2 24
$462.4M
$11.1M
Q1 24
$-75.4M
$-100.0K
FCF Margin
IVZ
IVZ
JBTM
JBTM
Q4 25
25.5%
8.3%
Q3 25
35.7%
5.6%
Q2 25
35.0%
9.0%
Q1 25
-7.1%
1.7%
Q4 24
19.5%
25.4%
Q3 24
27.1%
14.3%
Q2 24
31.2%
2.8%
Q1 24
-5.1%
-0.0%
Capex Intensity
IVZ
IVZ
JBTM
JBTM
Q4 25
1.4%
3.4%
Q3 25
1.2%
3.1%
Q2 25
1.2%
2.0%
Q1 25
1.5%
2.3%
Q4 24
0.4%
2.1%
Q3 24
1.9%
1.5%
Q2 24
1.8%
2.6%
Q1 24
1.4%
2.7%
Cash Conversion
IVZ
IVZ
JBTM
JBTM
Q4 25
2.21×
Q3 25
1.70×
1.33×
Q2 25
2.78×
30.06×
Q1 25
-0.49×
Q4 24
1.51×
Q3 24
7.97×
1.85×
Q2 24
3.70×
0.70×
Q1 24
-0.38×
0.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

JBTM
JBTM

Segment breakdown not available.

Related Comparisons